Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022

/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing,...

Related Keywords

China ,New York ,United States ,Xu Ping ,Gansu ,City Of New York ,Cayman Islands ,British Virgin Islands ,William Zima ,Cellenkos Inc ,Incyte Corporation Nasdaq ,Federal Reserve Bank ,Investor Relations Department ,Global Cord Blood Corporation ,Icr Inc ,Us Public Company Accounting Oversight Board ,Prnewswire Global Cord Blood Corporation ,Exchange Commission ,Development Expenses ,Securities Exchange ,Other Services ,Profit Down ,Income Down ,Cord Blood Corporation ,Quarter Fiscal ,Year Fiscal ,Ting Zheng ,Chief Executive Officer ,Fourth Quarter ,Full Year Ended March ,Months Ended March ,Ended March ,Selected Cash Flow Statement ,Incyte Corporation ,Blue Ocean Structure Investment Company Limited ,Blue Ocean ,Securities Act ,Securities Exchange Act ,Company Accounting Oversight Board ,Global Cord Blood ,Three Months ,Year Ended March ,Global Cord ,Cord Blood ,